查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589642

大肠桿菌测试市场：通过测试、最终用户 - 2025-2030 年全球预测

E. Coli Testing Market by Testing (Clinical, Environmental), End-User (Bottled Water Suppliers, Diagnostic Laboratories, Government Agencies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年大肠桿菌检测市值为9.9617亿美元，预计到2024年将达到10.9686亿美元，复合年增长率为10.20%，预计到2030年将达到19.6626亿美元。

E. 大肠桿菌检测的范围和定义包括旨在检测大肠桿菌存在的诊断程序，并用于改善各领域的公共卫生和安全，包括食品和水安全、医疗诊断和药物。为了满足监管机构和消费者对严格安全通讯协定的要求，对大肠桿菌检测的需求至关重要，因为大肠桿菌可能导致严重疾病和集体爆发。大肠桿菌测试在各种最终用途领域都有治疗应用，包括需要快速诊断的医疗保健、需要严格测试标准以防止污染的食品行业，以及定期监测对公共很重要的水处理设施。的应用领域。

主要市场统计
基准年[2023] 9.9617亿美元
预计年份 [2024] 1,096,860,000 美元
预测年份 [2030] 1,966.26 百万美元
复合年增长率（%） 10.20%

市场成长主要受到人们对食品源性疾病和水源性疾病认识的提高、严格的政府法规、检测方法的技术进步以及对预防性医疗保健的日益重视的影响。最新的潜在机会在于开发快速、经济高效且灵敏的检测套组，以及人工智慧和实验室晶片技术的整合以提高准确性和效率。他们还应重点将测试解决方案扩展到低收入地区，以解决具有巨大成长潜力的未满足需求。然而，先进检测技术高成本、新兴国家基础设施缺乏以及监管障碍等限制因素为市场拓展带来了挑战。

创新和研究的最佳领域包括开发提供即时结果、缩短治疗时间并改善管理结果的就地检验设备。此外，生物资讯学和次世代定序研究可以帮助我们更准确地检测和分类大肠桿菌。市场竞争激烈，特点是持续的技术创新和策略合併，重点是加强产品系列。因此，投资研究合作以及与学术和医疗机构合作的公司可能会在这个不断发展的环境中拥有竞争优势。

市场动态：快速发展的大肠桿菌测试市场的关键市场洞察

大肠桿菌检测市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 腹泻病例数增加
    • 食品回收数量增加
    • 大量食用方便食品
  • 市场限制因素
    • 大肠桿菌检测缺乏标准化
  • 市场机会
    • 食品安全测量创新技术介绍
    • 持续开发 PCR 技术以改善病原体检测
  • 市场挑战
    • 测试食品和水的高成本

波特的五力：驾驭大肠桿菌测试市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解大肠桿菌检测市场的外部影响

外部宏观环境因素在塑造大肠桿菌检测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 E. 了解大肠桿菌检测市场的竞争状况

对大肠桿菌测试市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵 E. 大肠桿菌测试市场供应商绩效评估

FPNV定位矩阵是评估大肠桿菌测试市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议 E. 绘製大肠桿菌检测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对大肠桿菌检测市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 腹泻发生率增加
      • 食品回收数量增加
      • 大量食用即食食品
    • 抑制因素
      • 大肠桿菌检测缺乏标准化
    • 机会
      • 食品安全测量创新技术介绍
      • 持续开发 PCR 技术以改善病原体检测
    • 任务
      • 食品和水测试成本高昂
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 大肠桿菌测试市场

  • 临床
    • 酵素免疫分析法
    • 聚合酵素链锁反应
  • 环境
    • 酵素基材法
    • 薄膜过滤
    • 多管发酵

第 7 章 大肠桿菌测试市场：依最终使用者分类

  • 瓶装水供应商
  • 诊断实验室
  • 政府机构
  • 生活用水和饮用水供应商
  • 医院
  • 污水处理机构

第八章 美洲大肠桿菌检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章 亚太地区大肠桿菌检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲大肠桿菌检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioSpace, Inc.
  • BIOTOXICITY
  • Caisson Labs Inc.
  • Corning Incorporated
  • Cygnus Technologies by Maravai LifeSciences
  • Enzo Life Sciences, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Intertek Group PLC
  • Lonza Group Ltd.
  • Merck & Co., Inc
  • Merck KGaA
  • SGS SA
  • Thermo Fisher Scientific Inc.
Product Code: MRR-4348D129FACF

The E. Coli Testing Market was valued at USD 996.17 million in 2023, expected to reach USD 1,096.86 million in 2024, and is projected to grow at a CAGR of 10.20%, to USD 1,966.26 million by 2030.

The scope and definition of E. Coli testing encompass diagnostic procedures aimed at detecting the presence of Escherichia coli bacteria, crucial for ensuring public health and safety across various sectors, including food and water safety, medical diagnostics, and pharmaceuticals. The necessity of E. Coli testing is paramount due to the bacterium's potential to cause severe illness and outbreaks, driving regulatory and consumer demand for rigorous safety protocols. Applications of E. Coli testing cover diverse end-use sectors such as healthcare settings where rapid diagnostics are essential, the food industry which demands stringent testing standards to prevent contamination, and water treatment facilities where regular monitoring is critical to public safety.

KEY MARKET STATISTICS
Base Year [2023] USD 996.17 million
Estimated Year [2024] USD 1,096.86 million
Forecast Year [2030] USD 1,966.26 million
CAGR (%) 10.20%

Market growth is primarily influenced by increasing awareness of food and waterborne diseases, stringent government regulations, technological advancements in testing methods, and a growing emphasis on preventive healthcare. The latest potential opportunities lie in the development of rapid, cost-effective, and highly sensitive testing kits, as well as the integration of artificial intelligence and lab-on-a-chip technologies to enhance accuracy and efficiency. Efforts should also be directed towards expanding testing solutions to lower-income regions, addressing an unmet need with significant growth potential. However, limitations such as high costs of advanced testing technologies, lack of infrastructure in developing regions, and regulatory hurdles can pose challenges to market expansion.

The best areas for innovation and research include the development of point-of-care testing devices that allow for real-time results, thereby reducing time-to-treatment and improving management outcomes. Also, exploring bioinformatics and next-generation sequencing can foster even more accurate detection and classification of E. Coli strains. The market nature is competitive, characterized by ongoing technological innovation and strategic mergers, focusing on enhancement of product portfolios. Thus, businesses investing in robust research and collaborations with academic and healthcare institutions are likely to gain a competitive edge in this evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving E. Coli Testing Market

The E. Coli Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of diarrhea
    • Rise in numbers of food recalls
    • Significant consumption of convenience foods
  • Market Restraints
    • Lack of standardizations in E.coli testing
  • Market Opportunities
    • Introduction of innovative technologies in food safety measurements
    • Ongoing developments of PCR technology for improved pathogen testing
  • Market Challenges
    • Associated high cost of testing food and water

Porter's Five Forces: A Strategic Tool for Navigating the E. Coli Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the E. Coli Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the E. Coli Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the E. Coli Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the E. Coli Testing Market

A detailed market share analysis in the E. Coli Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the E. Coli Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the E. Coli Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the E. Coli Testing Market

A strategic analysis of the E. Coli Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the E. Coli Testing Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioSpace, Inc., BIOTOXICITY, Caisson Labs Inc., Corning Incorporated, Cygnus Technologies by Maravai LifeSciences, Enzo Life Sciences, Inc., F. Hoffmann-La Roche Ltd., Intertek Group PLC, Lonza Group Ltd., Merck & Co., Inc, Merck KGaA, SGS SA, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the E. Coli Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Testing, market is studied across Clinical and Environmental. The Clinical is further studied across Enzyme Immunoassays and Polymerase Chain Reaction. The Environmental is further studied across Enzyme Substrate Methods, Membrane Filtration, and Multiple Tube Fermentation.
  • Based on End-User, market is studied across Bottled Water Suppliers, Diagnostic Laboratories, Government Agencies, Home & Drinking Water Suppliers, Hospitals, and Waste Water Treatment Agencies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of diarrhea
      • 5.1.1.2. Rise in numbers of food recalls
      • 5.1.1.3. Significant consumption of convenience foods
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of standardizations in E.coli testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of innovative technologies in food safety measurements
      • 5.1.3.2. Ongoing developments of PCR technology for improved pathogen testing
    • 5.1.4. Challenges
      • 5.1.4.1. Associated high cost of testing food and water
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. E. Coli Testing Market, by Testing

  • 6.1. Introduction
  • 6.2. Clinical
    • 6.2.1. Enzyme Immunoassays
    • 6.2.2. Polymerase Chain Reaction
  • 6.3. Environmental
    • 6.3.1. Enzyme Substrate Methods
    • 6.3.2. Membrane Filtration
    • 6.3.3. Multiple Tube Fermentation

7. E. Coli Testing Market, by End-User

  • 7.1. Introduction
  • 7.2. Bottled Water Suppliers
  • 7.3. Diagnostic Laboratories
  • 7.4. Government Agencies
  • 7.5. Home & Drinking Water Suppliers
  • 7.6. Hospitals
  • 7.7. Waste Water Treatment Agencies

8. Americas E. Coli Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific E. Coli Testing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa E. Coli Testing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Becton, Dickinson and Company
  • 2. Bio-Rad Laboratories, Inc.
  • 3. BioSpace, Inc.
  • 4. BIOTOXICITY
  • 5. Caisson Labs Inc.
  • 6. Corning Incorporated
  • 7. Cygnus Technologies by Maravai LifeSciences
  • 8. Enzo Life Sciences, Inc.
  • 9. F. Hoffmann-La Roche Ltd.
  • 10. Intertek Group PLC
  • 11. Lonza Group Ltd.
  • 12. Merck & Co., Inc
  • 13. Merck KGaA
  • 14. SGS SA
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. E. COLI TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. E. COLI TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL E. COLI TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL E. COLI TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL E. COLI TESTING MARKET SIZE, BY TESTING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL E. COLI TESTING MARKET SIZE, BY TESTING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL E. COLI TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL E. COLI TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES E. COLI TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES E. COLI TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. E. COLI TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. E. COLI TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. E. COLI TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL E. COLI TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL E. COLI TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. E. COLI TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL E. COLI TESTING MARKET SIZE, BY ENZYME IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL E. COLI TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL E. COLI TESTING MARKET SIZE, BY ENZYME SUBSTRATE METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL E. COLI TESTING MARKET SIZE, BY MEMBRANE FILTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL E. COLI TESTING MARKET SIZE, BY MULTIPLE TUBE FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL E. COLI TESTING MARKET SIZE, BY BOTTLED WATER SUPPLIERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL E. COLI TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL E. COLI TESTING MARKET SIZE, BY GOVERNMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL E. COLI TESTING MARKET SIZE, BY HOME & DRINKING WATER SUPPLIERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL E. COLI TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL E. COLI TESTING MARKET SIZE, BY WASTE WATER TREATMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES E. COLI TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. E. COLI TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. E. COLI TESTING MARKET, FPNV POSITIONING MATRIX, 2023